CCL3/MIP1α represents a biomarker but not a mandatory cytokine for disease development in experimental epidermolysis bullosa acquisita

Publication date: Available online 30 June 2017
Source:Journal of Dermatological Science
Author(s): Michael Kasperkiewicz, Kathrin Kalies, Rene Pagel, Katja Bieber, Detlef Zillikens, Ralf J. Ludwig




http://ift.tt/2ssNpwj